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pNIPAm particles for protein delivery to tumor-associated macrophages
Background
Macrophages are a type of white blood cell that engulf debris and pathogens in the
body. They exist as a spectrum of phenotypes, and upon exposure to specific
cytokines, they become activated to M1 (pro-inflammatory) or M2 (pro-angiogenic)
polarized macrophages. Evidence suggests tumor associated macrophages (TAM’s)
are polarized M2 and promote blood vessel formation.1 Exposure to the cytokine
interleukin 12 (IL-12) has been shown to reprogram M2 macrophages to M1 in vitro.2
The goal of this research is to
reprogram TAM’s to M1 activated
macrophages. A drug delivery
vehicle is an attractive method of
delivering IL-12 to macrophages,
due to improved longevity and
control of release. This work aimed
to determine if poly(ethylene
glycol)diacrylate (PEGDA) cross-
linked poly(N-isopropylacrylamide)
(pNIPAm) particles could be used to
deliver IL-12 to macrophages. These
particles are temperature and pH
sensitive; and degrade in water. Due
to their lower critical solution
temperature, the particles can be
loaded at room temperature and will
release contents at body
temperature.3,4
Synthesis of Particles
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Figure 1 – Pathways of macrophage polarization. M1 is 
associated with tumor suppression and M2 is associated with 
tumor promotion. Leyva-Illades et al. (2012)
Methods and Results
Particles were added to phosphate buffered saline (PBS) at pH 7.4 at 10mg/ml. They 
were incubated at 37ºC at different time lengths. Although the results were inconclusive, 
the data suggest an upward trend.
Doxorubicin is a cancer drug that kills macrophages. Internalization was determined using a 
doxorubicin kill curve and MTT assay. Doxorubicin was delivered at varying concentrations and an 
MTT assay performed to determine the amount of cell death.
Figure 5 – Kill Curve for macrophages for doxorubicin and doxorubicin loaded particles.
Figure 6 – Images obtained by the FLoid Cell Imaging Station of 
internalized particles for NA, IL-4 and LPS activated cells.
Conclusions and Future Work 
Doxorubicin loaded particles were released from dialysis tubing into 100 mL of pH 7.4
and 5.0 PBS for 10 days.
Figure 7 – Concentration of Doxorubicin over time. 
Degradation of pNIPAm-co-AAc-co-PEGDA was shown, an attractive property for protein
delivery. Viability of cells in response to these particles was high, enhancing potential for
use in protein delivery. Cellular reprogramming was not found from exposure to particles,
however further studies into functionalization of these particles may show
reprogramming and selective internalization by different macrophage phenotypes.
Phagocytosis of particles was shown through a FITC assay and cell imaging cells
incubated with FITC-loaded particles. Doxorubicin release was shown in small, slow
amounts, which is suitable for systemic delivery. These particles are able to be loaded
with BSA, a model protein for IL-12. Further studies include cold binding experiments, a
control for the localization of the particle to vs. internalization of the particle by
macrophages. Release of BSA from particles will also be studied at pH 7.4 and 5.0. The
potential of these particles for delivery of IL-12 to macrophages has been shown and will
be further studied.
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Mouse RAW 264.7 macrophages were activated with 5 μg/mL lipopolysaccharide (LPS),
10 ng/mL interleukin-4 (IL-4), or were not activated (NA). An MTT assay was carried out
to determine viabilities greater than 90%, indicating strong cytocompatibility.
Particle loading with BSA and FITC
1 mg/ml Fluorescein (FITC) was added to 10 mg/ml particles and incubated for 48 hours.
Trypan blue was used to quench to fluorescence that was not internalized.
Bovine Serum Albumin (BSA) was used as a model protein for IL-12, because it is readily
available and inexpensive. A BCA assay was performed to measure protein concentration
in supernatant. Efficiency was calculated by taking the difference of the supernatant
concentration and dividing by the original concentration. 1 mg/mL FITC in DMSO was
added to a 10 mg/mL solution of particles in pH 7.4 PBS and efficiency was determined.
The optimum loading efficiency and capacity for BSA was found to be 13 % and 9.67 x
10-10 mol BSA/mg particle, respectively. The loading efficiency of FITC was found to be
around 40 %.
Figure 2 – H-
NMR spectra of
pNIPAm-co-AAc-
co-PEGDA 
particles. 
pNIPAm-co-AAc-co-PEGDA particles were synthesized 
via free radical polymerization. H-NMR was taken of the 
particles to verify structure. Proton peaks were 
determined by comparing to H-NMR taken by Nolan et al. 
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Figure 4 - Viability 
of macrophage 
phenotypes in 
response to 
particles. All values 
normalized. 
Concentration of 
particles added 
was 0.625 mg/mL
